Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
290 CAD | +1.75% | 0.00% | -6.45% |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Apr. 04 | Biolinq Incorporated announced that it has received $58 million in funding from a group of investors | CI |
Sales 2022 | -740M -541M | Sales 2023 | 427M 313M | Capitalization | 766M 561M |
---|---|---|---|---|---|
Net income 2022 | -326M -239M | Net income 2023 | 83M 60.75M | EV / Sales 2022 | 4.28 x |
Net cash position 2022 | 3.97B 2.9B | Net cash position 2023 | 3.43B 2.51B | EV / Sales 2023 | -6.24 x |
P/E ratio 2022 |
-2.47
x | P/E ratio 2023 |
9.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 39.44% |
1 day | +1.75% | ||
Current month | +1.75% | ||
3 months | -9.02% | ||
6 months | +2.91% | ||
Current year | -6.45% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | - | |
Victor Mashaal
CHM | Chairman | - | 68-11-19 |
Frank Daniel
BRD | Director/Board Member | - | 71-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Victor Mashaal
CHM | Chairman | - | 68-11-19 |
Richard Mashaal
BRD | Director/Board Member | - | 00-12-31 |
Director/Board Member | - | 14-06-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 290 | +1.75% | 100 |
Delayed Quote Toronto S.E., April 29, 2024 at 11:20 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-6.45% | 514M | |
-6.22% | 113B | |
+20.42% | 63.85B | |
+5.53% | 61.9B | |
+10.14% | 42.86B | |
+9.61% | 40.84B | |
+18.75% | 34.58B | |
+4.08% | 25.46B | |
-4.48% | 22.13B | |
+2.24% | 18.61B |
- Stock Market
- Equities
- SEC Stock